Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/28/1990 | US4952602 Treatment of arteriosclerosis |
08/28/1990 | US4952600 3- or 4-substituted oxotremorine derivatives and a method of treating central chloinergic dsyfunction therewith |
08/28/1990 | US4952598 3-phenyl indolinone derivatives, processes for their preparation, medicaments containing them, and their use |
08/28/1990 | US4952596 Derivatives of thiazolidine-4-carboxylic acid having pharmacological activity |
08/28/1990 | US4952594 Reagents and method for therapeutic treatment of multiple sclerosis |
08/28/1990 | US4952593 5-heterocyclic-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants |
08/28/1990 | US4952592 Hypotensive, cardiotonic agents |
08/28/1990 | US4952591 Histamine h2-antagonists |
08/28/1990 | US4952589 Histamine h2-antagonists |
08/28/1990 | US4952587 Physiologically active 1,2,4,-oxa- and thiadiazoles |
08/28/1990 | US4952586 For antagonizing nondepolarizing neuromuscular blockade when muscle relaxation is not needed |
08/28/1990 | US4952585 Castanospermine esters in the inhibition of tumor metastasis |
08/28/1990 | US4952583 Diuretic hypotensive agents |
08/28/1990 | US4952582 Pyrazinoylguanidine and derivatives thereof having few polar substituents and being useful as hyperuretic agents |
08/28/1990 | US4952581 Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure |
08/28/1990 | US4952578 Cephem compound and a process for preparation thereof |
08/28/1990 | US4952577 Antibiotics |
08/28/1990 | US4952576 UCY1003 derivatives |
08/28/1990 | US4952575 Solutions of oxaphosphorins having improved stability and process for the preparation thereof |
08/28/1990 | US4952571 Treating heart failure or asthma |
08/28/1990 | US4952570 Antiprotozoa agents; coccidiosis |
08/28/1990 | US4952568 Remedies and preventives for diabetic diseases |
08/28/1990 | US4952567 Administering a protein kinase antagonist |
08/28/1990 | US4952566 Stabilized anthracycline preparation containing L-cysteine |
08/28/1990 | US4952565 Inclusion complex of ibuproxam with beta-cyclodextrin, a process for preparing the same and a pharmaceutical preparation containing the same |
08/28/1990 | US4952564 Antiallergic agent |
08/28/1990 | US4952411 Using mixture of silver salt and a biquanide |
08/28/1990 | US4952410 Synergistic mixture; hypotensive agents; diuretics; side effect reduction |
08/28/1990 | US4952408 Liposome-encapsulated vinca alkaloids and their use in combatting tumors |
08/28/1990 | US4952402 Edible taste-masked drugs; micromatrix active material coated with nontoxic polymer; liquids; tablets |
08/28/1990 | US4952397 2-quaternary heteroarylalkylthio carbapenems having an acid moiety substituent |
08/28/1990 | US4952396 Or salts or hydrolyzates; oral administration |
08/28/1990 | US4952391 Tert-butyl derivatives of benzylidenecamphor, process for preparing them, their use as antioxidant agents and cosmetic and pharmaceutical compositions containing them |
08/28/1990 | US4952288 From 4-furanylazetidin-2-one by oxidation with bromine and sodium chlorite and reaction with organic acid |
08/28/1990 | US4952232 Antifungal carbinols |
08/28/1990 | CA1273450A1 Nootropic imidazolidinomes |
08/28/1990 | CA1273360A1 Substituted phenylacetic acid amides and compositions thereof having anti-inflammatory and analgesic activity |
08/28/1990 | CA1273349A1 Leukotriene antagonists |
08/28/1990 | CA1273341A1 1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-2- substituted trimethylene-1-(3,4,5-trimethoxybenzyl)- isoquinoline compounds |
08/28/1990 | CA1273340A1 Furo- or pyrrolo-pyridine compounds, their preparation and pharmaceutical compositions containing them |
08/28/1990 | CA1273335A1 Pyrrolo¬1,2-a| ¬4,1|benzoxazepine derivatives |
08/28/1990 | CA1273297A1 Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido) azabicycloalkanes |
08/27/1990 | CA2362972A1 Process for preparing ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes |
08/27/1990 | CA2355852A1 Intermediates for the preparation of 1h-imidazo [4,5-c] quinolin-4-amines |
08/27/1990 | CA2010964A1 Post-ptca restenosis inhibitor |
08/27/1990 | CA2010769A1 Benzodiazepine analogs |
08/27/1990 | CA2010430A1 1h-imidazo¬4,5-c|quinolin-4-amines |
08/27/1990 | CA2010427A1 Pharmaceutical composition providing the sustained-release of valproic acid |
08/26/1990 | WO1990010006A2 NOVEL β-METHOXYACRYLATES, THEIR PRODUCTION AND USE |
08/26/1990 | CA2047195A1 .beta.-methoxyacrylates, their production and use |
08/25/1990 | WO1990010020A1 Novel compositions containing hyaluronic acid associates and a process for preparing same |
08/25/1990 | CA2010806A1 Streptenols from streptomycetes, and the preparation and use thereof |
08/24/1990 | WO1990009997A1 Novel benzimidazole derivatives |
08/24/1990 | WO1990009992A1 Novel vitamin d analogues |
08/24/1990 | WO1990009991A1 Novel vitamin d analogues |
08/24/1990 | CA2050908A1 Benzimidazole derivatives |
08/24/1990 | CA2010826A1 19-nor steroids having an 11-beta substituted carbon chain with an amide or carbamate function, process for their preparation and intermediates therefor, use as medicaments and pharmaceuticasl compositions containing the said steroids |
08/24/1990 | CA2010811A1 Tetrazole amide derivatives of heterocyclic alkenyl acids and their use as antiallergic substances |
08/23/1990 | WO1990009791A1 Pharmaceutical composition containing hydantoin derivative |
08/23/1990 | WO1990009401A1 Crosslinked hyaluronate gels, their use and method for producing them |
08/23/1990 | WO1990009381A1 4-hydroxythiazoles as 5-lipoxygenase inhibitors |
08/23/1990 | WO1990009379A1 Aza-macrocycles and processes for their preparation |
08/23/1990 | WO1990009377A1 Alcaline salts of 2-(2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine-4-carboxamido) ethane sulphonic acid and method of obtaining them |
08/23/1990 | WO1990009373A1 Hydroxyalkane carboxylic acid derivates, their manufacture and use |
08/23/1990 | WO1990009192A1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
08/23/1990 | WO1990009190A1 In ovo administration of growth factors alters physiological development and response of poultry |
08/23/1990 | WO1990009188A1 In ovo administration of growth factors alters physiological development and response of poultry |
08/23/1990 | WO1990009185A1 Composition and method for treatment of gastric and duodenal ulcers and mucosal erosions |
08/23/1990 | WO1990009183A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections |
08/23/1990 | WO1990009182A1 Pharmaceutical and veterinary compositions for the treatment or prevention of helminthiasis |
08/23/1990 | WO1990009180A1 Methods and compositions for treatment of cancer using oligonucleotides |
08/23/1990 | WO1990009179A1 Treatment of tibial dyschondroplasia |
08/23/1990 | WO1990009176A1 Composition for reparation and prevention of fibrotic lesions |
08/23/1990 | WO1990009173A1 Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin |
08/23/1990 | WO1990009171A1 Cardio-protective drug preparations comprising amiodarone, a nitrate derivate, in particular isosorbide dinitrate and optionally a beta-blocker |
08/23/1990 | WO1990009170A2 Agents for diagnosing and treating melanomas, aromatic halogenated derivatives usable as such agents and their preparation |
08/23/1990 | WO1990009163A2 Method and compounds for aica riboside delivery and for lowering blood glucose |
08/23/1990 | WO1990009092A2 Novel potent inducers of terminal differentiation and method of use thereof |
08/23/1990 | WO1990006313A3 Alkali and alkaline earth salts of oxypurinol in amorphous or crystalline form as agents for treating hyperuricemia and gout |
08/23/1990 | WO1990006116A3 Agents for treating chronic inflammatory diseases of the intestines |
08/23/1990 | WO1990006115A3 Preparations of oxypurinol and/or its alkali or alkaline earth salts |
08/23/1990 | DE3904795A1 Pharmaceutical product and diagnostic method |
08/23/1990 | DE3904593A1 Compositions against parasites of fish and insects |
08/23/1990 | CA2010713A1 1-arylsulfonyl pyrrolidine-2-thione ou 1-arylsulfonyl piperidine-2-thione derivatives, process for their preparation, use as medicament and compositions containing the same |
08/23/1990 | CA2010600A1 Use of paf-antagonists for treating pathological changes in blood gas |
08/23/1990 | CA2008115A1 Deodorant compositions containing specific piroctone salts and perfumes |
08/22/1990 | WO1990009808A1 Device for the transdermal delivery of nicotine |
08/22/1990 | EP0383690A1 Derivatives of 2-amino-pentanedioic acid, process for their preparation and intermediates, their use as medicines and compositions containing them |
08/22/1990 | EP0383686A1 2-Amino-7-hydroxytetraline carboxyalkyl ethers |
08/22/1990 | EP0383680A2 Pentamidine solutions |
08/22/1990 | EP0383635A2 Peptides having renin inhibitory activity their preparation and use |
08/22/1990 | EP0383607A1 Tris-hydroxymethyl lower alkane esters as fat mimetics |
08/22/1990 | EP0383591A2 Use of 5-methyl-1-phenyl-2-(1H)-pyridone in the prevention and treatment of fibrotic lesions |
08/22/1990 | EP0383579A1 N-Phenyl-N-(4-piperidinyl)amides useful as analgesics |
08/22/1990 | EP0383531A2 6'-deoxy-6'-halogenoneplanosin A and its production |
08/22/1990 | EP0383513A2 Avermectin derivatives |
08/22/1990 | EP0383504A2 Decahydro isoquinoline derivatives, process for their preparation and use as medicines |
08/22/1990 | EP0383481A2 Anesthetic oral compositions |
08/22/1990 | EP0383467A2 Medicament for use in combatting hair loss and/or dandruff |
08/22/1990 | EP0383465A2 Tricyclic fused pyrimidine derivatives, their production and use |